Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP822618.RARNY6tGmZ-HJjfqWDKGzVjeA4Dp9J2U19lFdfLUvFp8g130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP822618.RARNY6tGmZ-HJjfqWDKGzVjeA4Dp9J2U19lFdfLUvFp8g130_assertion type Assertion NP822618.RARNY6tGmZ-HJjfqWDKGzVjeA4Dp9J2U19lFdfLUvFp8g130_head.
- NP822618.RARNY6tGmZ-HJjfqWDKGzVjeA4Dp9J2U19lFdfLUvFp8g130_assertion description "[Our data suggest that the molecular signature identified by the ENPP2-silencing methods may represent potential candidates that can explain the complicated characteristics of ATX and may serve as biomarkers, for the development of molecular-targeting therapy, in human breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP822618.RARNY6tGmZ-HJjfqWDKGzVjeA4Dp9J2U19lFdfLUvFp8g130_provenance.
- NP822618.RARNY6tGmZ-HJjfqWDKGzVjeA4Dp9J2U19lFdfLUvFp8g130_assertion evidence source_evidence_literature NP822618.RARNY6tGmZ-HJjfqWDKGzVjeA4Dp9J2U19lFdfLUvFp8g130_provenance.
- NP822618.RARNY6tGmZ-HJjfqWDKGzVjeA4Dp9J2U19lFdfLUvFp8g130_assertion SIO_000772 16601922 NP822618.RARNY6tGmZ-HJjfqWDKGzVjeA4Dp9J2U19lFdfLUvFp8g130_provenance.
- NP822618.RARNY6tGmZ-HJjfqWDKGzVjeA4Dp9J2U19lFdfLUvFp8g130_assertion wasDerivedFrom befree-20140225 NP822618.RARNY6tGmZ-HJjfqWDKGzVjeA4Dp9J2U19lFdfLUvFp8g130_provenance.
- NP822618.RARNY6tGmZ-HJjfqWDKGzVjeA4Dp9J2U19lFdfLUvFp8g130_assertion wasGeneratedBy ECO_0000203 NP822618.RARNY6tGmZ-HJjfqWDKGzVjeA4Dp9J2U19lFdfLUvFp8g130_provenance.